International Program Spotlights the BRICs at the 2013 BIO International Convention

03/20/2013 22:34:26

Washington, DC (February 13, 2013) C With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities within emerging markets and strategies for growing the global biotech industry.... ...

Read More

FDA Delay of Salmon Approval is a Blow to Science and Business

03/20/2013 22:34:15

The U.S. Food and Drug Administration (FDA) announced today that it is extending for 60 days the comment period for the genetically engineered AquAdvantage Salmon.... ...

Read More

Farmers Increasingly Favor Biotech Crops

03/20/2013 22:34:06

Farmers around the world continue to adopt genetically engineered (GE) crops because of their tremendous environmental and economic benefits as well as their ability to contribute to food security, according to a report released today by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA).... ...

Read More

BIO Welcomes EPA Final Rule on New Advanced and Cellulosic Biofuels

03/20/2013 22:33:57

On Friday, the U.S. Environmental Protection Agency issued long-awaited approval for new feedstocks and biofuel processes under the Renewable Fuel Standard.... ...

Read More

2013 BIO International Convention to Host Orphan Disease Forum

03/20/2013 22:33:45

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of big pharmaceutical companies and U.S. legislation favoring development and coverage.... ...

Read More

BIO Statement on Whole Foods Announcement to Label all GMOs Products in their Stores by 2018

03/20/2013 22:33:27

Whole Foods announced today that it will require the makers of food products sold in its stores to state on the label if a product contains an ingredient produced through agricultural biotechnology.... ...

Read More

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Incyte Corporation

03/13/2013 21:54:30

The Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Delaware District Court on behalf of all purchasers of the common stock of Incyte Corporation (Incyte or the Company) (INCY) between April 26, 2012 and August 1, 2012, inclusive (the Class Period).... ...

Read More

Achillion: A Tiny Biopharmaceutical Stock With Tremendous Potential

03/13/2013 21:54:19

I am not sure if many of my readers are aware of the first time I wrote about Achillion (ACHN). It was back in October of 2012, and the article opened up many investors' eyes to this stock. Of course, if you had purchased the stock back then, you would be underwater by maybe $.50/share or so. Since that time, I have been following the progress that this company has been making with its hepatitis C drugs.... ...

Read More

Cerus to Float Issue of Common Stock

03/13/2013 21:54:05

Cerus (NASDAQ: CERS ) will float a new offering of common stock in an underwritten public offering.The pharma company didn't disclose the number of shares that will be offered, nor did it specify how much it intended to raise from the issue. It did say that it intends to use the funds "for clinical development and other research and development activities" connected with its key product, the INTERCEPT Blood System.... ...

Read More

Amicus Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript

03/13/2013 01:24:53

Good day, ladies and gentlemen. And welcome to the Amicus Therapeutics full year 2012 results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. (Operator instructions) As a reminder, this conference call is being recorded. I would now like to introduce your host for todays conference, Sara Pellegrino. Ma'am, you may begin.... ...

Read More